OBJECTIVE: To explore the accuracy and performance of a new transcutaneous bilirubinometer (TCB) for the screening of @entity1087 in late preterm and term @entity1 . METHODS: A cross sectional study was conducted. TCB measurements were performed using the BiliCare(TM) bilirubinometer. Paired TCB and serum @entity648 (SB) measurements were analysed. RESULTS: 114 paired samples were collected from 93 healthy late preterm and term @entity1 . @entity648 measurements were done at median (interquartile range) of 50.5 (34, 72) hours. The mean (SD) difference between the TCB and SB was 1.87 (1.98) mg/dL. A TCB cut-off level at 8.0 mg/dL provides a sensitivity of 97.3% with a negative predictive value (NPV) of 87.5% to detect a SB level of at least 8.0 mg/dL. For SB levels of at least 10.0 mg/dL, a TCB cut-off at 9.0 mg/dL shows a sensitivity of 97.5%; NPV 95.4%. For a SB level of at least 13.0 mg/dL, a TCB cut-off at 12 or 13 mg/dL had a sensitivity of 92.9% and NPV of 98.7%. CONCLUSION: The BiliCare(TM) demonstrated good performance with positive bias for the screening of @entity1087 in healthy late preterm or term @entity1 . However, if adopted, proper cut-off levels should be chosen because of sub-optimal device precision.

Accuracy of transcutaneous XXXX measured by the BiliCare(TM) device in late preterm and term neonates.

@entity1 :: ('9606', 'Species') :: ['infants'] @entity648 :: ('MESH:D001663', 'Chemical') :: ['bilirubin', 'Bilirubin'] @entity1087 :: ('MESH:D007565', 'Disease') :: ['jaundice']
@entity648 :: (MESH:D001663,Chemical) :: ['bilirubin']
